| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/31/2013 | US20130030526 Crosslinked human or animal tissue products and their methods of manufacture and use |
| 01/31/2013 | US20130030047 Fatty Acid Derivatives of Catechins and Methods of Their use |
| 01/31/2013 | US20130030042 Nucleic acids for targeting multiple regions of the hcv genome |
| 01/31/2013 | US20130030037 RNAi Modulation Of RSV And Therapeutic Uses Thereof |
| 01/31/2013 | US20130030027 Hemi-phorboxazole a derivatives and methods of their use |
| 01/31/2013 | US20130030024 Method of Administering Pirfenidone Therapy |
| 01/31/2013 | US20130030017 Quinoline derivatives as antibacterial agents |
| 01/31/2013 | US20130030016 Quinoline derivatives as antibacterial agents |
| 01/31/2013 | US20130030005 Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives with protease inhibitors |
| 01/31/2013 | US20130030004 Gyrase inhibitors and uses thereof |
| 01/31/2013 | US20130029995 Substituted Bicyclic Aromatic Carboxamide and Urea Compounds as Vanilloid Receptor Ligands |
| 01/31/2013 | US20130029985 Novel Compounds |
| 01/31/2013 | US20130029981 Compounds, compositions, and methods for controlling biofilms |
| 01/31/2013 | US20130029980 Flavin derivatives |
| 01/31/2013 | US20130029977 Fused substituted aminopyrrolidine derivative |
| 01/31/2013 | US20130029974 6,7-dihydroimidazo[1,5-a]pyrazin-8(5h)-one derivatives as protein kinase modulators |
| 01/31/2013 | US20130029961 Substituted Heterocyclic Aza Compounds |
| 01/31/2013 | US20130029954 C-28 amines of c-3 modified betulinic acid derivatives as hiv maturation inhibitors |
| 01/31/2013 | US20130029945 Darunavir Polymorph and Process for Preparation Thereof |
| 01/31/2013 | US20130029943 Methods of Preparing Substituted Tetracyclines with Transition Metal-Based Chemistries |
| 01/31/2013 | US20130029940 Phosphonates with reduced toxicity for treatment of viral infections |
| 01/31/2013 | US20130029939 Novel glucokinase activators and methods of using same |
| 01/31/2013 | US20130029929 Nucleoside phosphoramidate prodrugs |
| 01/31/2013 | US20130029924 Glycosylated valproic acid analogs and uses thereof |
| 01/31/2013 | US20130029923 Materials and Methods for Prevention and Treatment of Viral Infections |
| 01/31/2013 | US20130029904 Hcv combination therapy |
| 01/31/2013 | US20130029903 Azuvirin Peptides |
| 01/31/2013 | US20130029902 Cxc chemokine receptor 4 (cxcr4) antagonistic polypeptide |
| 01/31/2013 | US20130029901 Methods and compounds for the targeted delivery of agents to bone for interaction therewith |
| 01/31/2013 | US20130029900 Novel maytansinoid derivatives with peptide linker and conjugates thereof |
| 01/31/2013 | US20130028997 Compositions, Products, Therapeutic Uses and Procedures for the Production and/or Crystallization of Extracts of Encelia Canescens LAM (Coronilla De Fraile) |
| 01/31/2013 | US20130028995 New synergistic compositions for the treatment of topical viral infections |
| 01/31/2013 | US20130028992 Herbal-Based Solution for Treating Symptoms of Nasal Conditions |
| 01/31/2013 | US20130028989 Materials and method for inhibiting replication protein a and uses thereof |
| 01/31/2013 | US20130028987 Method of treating psoriasis |
| 01/31/2013 | US20130028984 Natural tissue scaffolds as tissue fillers |
| 01/31/2013 | US20130028971 Pharmaceutical Compositions Comprising Rifaximin, Processes For Their Preparation And Their Use In The Treatment Of Vaginal Infections |
| 01/31/2013 | US20130028968 Compositions and methods to relieve chronic diseases symptoms |
| 01/31/2013 | US20130028966 Broad Spectrum Antiviral and Antiparasitic Agents |
| 01/31/2013 | US20130028965 NOVEL RNAi THERAPEUTIC FOR TREATMENT OF HEPATITIS C INFECTION |
| 01/31/2013 | US20130028964 NOVEL RNAi THERAPEUTIC FOR TREATMENT OF HEPATITIS C INFECTION |
| 01/31/2013 | US20130028962 Triggered Cargo Release from Nanoparticle Stabilized Liposomes |
| 01/31/2013 | US20130028960 Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof |
| 01/31/2013 | US20130028959 Liposomes for Preventing the Spread of HIV |
| 01/31/2013 | US20130028955 Sustained release oral matrix and methods of making thereof |
| 01/31/2013 | US20130028947 Pharmaceutical composition for topical application |
| 01/31/2013 | US20130028941 Synthetic nanocarriers that generate humoral and cytotoxic t lymphocyte (ctl) immune responses |
| 01/31/2013 | US20130028940 Caspofungin formulations |
| 01/31/2013 | US20130028939 Chimeric human beta defensins |
| 01/31/2013 | US20130028934 Stabilizer and Vaccine Composition Comprising One or More Live Attenuated Flaviviruses |
| 01/31/2013 | US20130028933 Methods for stabilizing influenza antigen enveloped virus-based virus-like particle solutions |
| 01/31/2013 | US20130028932 Compositions comprising polyglutamic acid nanoparticles and polypeptides such as cd40 agonists |
| 01/31/2013 | US20130028931 Novel prrs virus inducing type i interferon in susceptible cells |
| 01/31/2013 | US20130028930 Albumin Derivatives and Variants |
| 01/31/2013 | US20130028928 Methods to increase antigenicity of membrane bound polypeptides produced in plants |
| 01/31/2013 | US20130028927 Method of diagnosing and treating melioidosis |
| 01/31/2013 | US20130028925 Herpes simplex virus combined subunit vaccines and methods of use thereof |
| 01/31/2013 | US20130028924 Constructs for enhancing immune responses |
| 01/31/2013 | US20130028920 Stabilized antibody preparations and uses thereof |
| 01/31/2013 | US20130028913 Antibody that binds to h-1 parvovirus |
| 01/31/2013 | US20130028910 Hmg1 antibody for treating inflammatory conditions |
| 01/31/2013 | US20130028908 MONOCLONAL ANTIBODIES DIRECTED AGAINST HIV p17 PROTEIN |
| 01/31/2013 | US20130028901 Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof |
| 01/31/2013 | US20130028887 Phenylacetic acid compound |
| 01/31/2013 | US20130028882 Antiviral compositions and methods of their use |
| 01/31/2013 | US20130028877 LACTOBACILLUS JOHNSONII La1 NCC533 (CNCM I-1225) AND IMMUNE DISORDERS |
| 01/31/2013 | US20130028867 Long-acting interferon beta formulation using immunoglobulin fragment |
| 01/31/2013 | US20130028865 Combination of a Macrocyclic Inhibitor of HCV, A Non-Nucleoside and a Nucleoside |
| 01/31/2013 | US20130028859 Hepatitis C Virus Inhibitors |
| 01/31/2013 | US20130028850 Topical tetracycline compositions |
| 01/31/2013 | US20130028848 Method of inhibiting harmful microorganisms and barrier-forming composition therefor |
| 01/31/2013 | US20130028844 Preparations for effervescent formulations comprising cephalosporin and uses thereof |
| 01/31/2013 | CA2842838A1 9-aminomethyl substituted tetracycline compounds |
| 01/31/2013 | CA2842779A1 Pharmaceutical compositions comprising beta-lactam antibiotic, sulbactam and beta-lactamase inhibitor |
| 01/31/2013 | CA2842777A1 Pharmaceutical compositions comprising sulbactam and beta-lactamase inhibitor |
| 01/31/2013 | CA2842626A1 Methods and compositions for vaccinating against staphylococcus aureus |
| 01/31/2013 | CA2842508A1 Bis-indolic derivatives, their uses in particular as antibacterials |
| 01/31/2013 | CA2842501A1 Bis-indolic derivatives, a process for preparing the same and their uses as a drug |
| 01/30/2013 | EP2551345A1 Hcv variant with high productivity of infectious hepatitis c virus, and use thereof |
| 01/30/2013 | EP2551266A1 2',2-dithiazol non-nucleoside compounds, preparation methods, pharmaceutical compositions and uses as hepatitis virus inhibitors thereof |
| 01/30/2013 | EP2550360A1 Bivalent antisense oligonucleotides |
| 01/30/2013 | EP2550298A2 Compositions and methods for self-adjuvanting vaccines against microbes and tumors |
| 01/30/2013 | EP2550292A2 Flavivirus host range mutations and uses thereof |
| 01/30/2013 | EP2550285A1 Trioxacarcins and uses thereof |
| 01/30/2013 | EP2550267A1 Analogues for the treatment or prevention of flavivirus infections |
| 01/30/2013 | EP2549993A2 Antimicrobial compositions |
| 01/30/2013 | EP2549990A1 Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc. |
| 01/30/2013 | EP2406206B1 Tetrahydronaphthalen-2-ol derivatives |
| 01/30/2013 | CN102906266A Universal dengue virus sequences and methods of use |
| 01/30/2013 | CN102906110A Antimicrobial agents based on hemin derivatives |
| 01/30/2013 | CN102906105A Compounds and their use |
| 01/30/2013 | CN102906102A Stereoselective synthesis of phosphorus containing actives |
| 01/30/2013 | CN102906087A Process for the preparation of chiral triazolones |
| 01/30/2013 | CN102906080A Compounds for the treatment of hepatitis C |
| 01/30/2013 | CN102905703A Compounds (cystein based lipopeptides) and compositions as TLR2 agonists used for treating infections, inflammations, respiratory diseases, etc. |
| 01/30/2013 | CN102905701A 1-(2-fluorobiphenyl-4-yl)-cyclopropanecarboxylic acid derivatives for the therapy of prion diseases |
| 01/30/2013 | CN102905699A Anti-fungal agent |
| 01/30/2013 | CN102905698A Combination therapy comprising CCR5 antagonist, HIV-1 protease inhibitor and pharmacokinetic enhancer |
| 01/30/2013 | CN102905693A Water-soluble pharmaceutical composition comprising at least one therapeutically active substance having hydrophobic properties and at least one compound selected from among sialoglycosphingolipids, glycosphingolipids or a mixture of sialoglycosphingolipids and glycosphingolipids |
| 01/30/2013 | CN102902895A Compound for preventing and treating human papillomavirus infection disease and screening method of compound |